Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma

Name: Tirelizumab Plus Surgery vs Surgery Alone for Recurrent Nasopharyngeal Carcinoma
License: Public Domain

Eye & ENT Hospital of Fudan University

ClinicalTrials.gov · Datasets · License: Public Domain

nasopharyngeal carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 414500
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.